Just a moment...
Convert scanned orders, printed notices, PDFs and images into clean, searchable, editable text within seconds. Starting at 2 Credits/page
Try Now →Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: Whether Modvat credit was admissible on disposable syringes and needles packed along with injections on the footing that they were used in relation to manufacture or constituted packing material.
Analysis: The Tribunal noted that in the assessee's own earlier case it had already been held that the manufacture and packing of the medicine was complete when the medicine was put in ampoule, that the ampoule was a complete product capable of independent marketability, and that syringe and needle could not be treated as packing material. The contrary decisions cited by the assessee were from Single Member Benches, whereas the earlier decision relied upon by the Revenue was a Division Bench decision in the assessee's own case. Following judicial discipline and the earlier binding view on the same dispute, the Tribunal declined to refer the matter to a Larger Bench.
Conclusion: Modvat credit on disposable syringes and needles was not admissible, and the appeal was rejected.
Ratio Decidendi: Where an earlier decision in the assessee's own case has held that the item is not packing material and that the product is complete and marketable independently, judicial discipline requires adherence to that view in the absence of a contrary binding decision.